Lunch Workshop: Bridging the Gap: Next-Generation Manufacturing Strategies for Cell and Gene Therapy

***THIS SESSION NOW TAKING PLACE IN THE PARTNER & INDUSTRY TRACK ROOM***

This workshop will focus on exploring advanced manufacturing strategies to overcome the current constraints in the cell and gene therapy sector. Facilitating discussions around mobilising established infrastructure, identifying existing gaps, and the critical role of automation and digitisation. Additionally , we will strategize on creating an integrated global ecosystem to ensure resilient and efficient manufacturing and logistics.

WHAT TO EXPECT

Part 1: Opening remarks from the chairs and a few introductory slides to set the scene

Part 2: The panel will address key challenges associated with current manufacturing strategies and provide a vision for industrialisation in the sector

Assess the capabilities and limitations of existing manufacturing infrastructure.

Conduct a concise review of the key gaps hindering scalable and robust manufacturing.

Discuss the importance of automation and digitisation for robust manufacturing chains.

Discuss requirements on forming an integrated global ecosystem for efficient logistics and just-in-time production.

Part 3: The panel answers audience questions with an interactive Q&A.

• Dan Gibson, Head of Collaborations, CGT Catapult

• Jason Jones, Global Business Development Lead, Cellular Origins

• Amol Ketkar, Chief Manufacturing & Technical Operations Officer, Resolution Therapeutics

• Rhys Macown, Lead Scientist, CGT Catapult